Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
Go back to Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO-01| (NASDAQ: GLSI) | Delayed: 14.44 -0.51 (3.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.95 | 52 Week High | $ | |||
| Open | $14.56 | 52 Week Low | $ | |||
| Day High | $15.01 | P/E | N/A | |||
| Day Low | $14.40 | EPS | $ | |||
| Volume | 22,738 | |||||

